Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07454785

Neuronal Mechanisms of Learning and Utilizing Abstract Representations

The purpose of this study is to examine how memories of past experiences are used to guide behavior in novel situations through the cognitive process of abstraction. This project examines how abstract representations are learned, whether and how they support generalization to novel situations, and whether and how they support analogical reasoning.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States

About this study

Despite the importance of abstraction for human cognition, little is known about the underlying mechanisms and their disruption by disease or injury. The goal of this research is to develop a circuit-level understanding of abstraction to enable the development of new treatments for the devastating effects of cognitive disorders in which abstraction fails. As part of this study, investigators will conduct experiments that utilize the rare opportunity to record in-vivo from human single neurons simultaneously in multiple brain areas in patients undergoing treatment for drug resistant epilepsy.

Researchers will investigate three overarching hypotheses on the neural substrate of abstraction. Aim 1: to determine the dynamics of learning abstract representations. Aim 2: to decipher how abstract representations facilitate generalization. Aim 3: to decipher how abstract representations facilitate analogical reasoning.

The expected outcomes of this work are a characterization of how abstract neural representations are formed, how they enable generalization to novel stimuli and tasks, and how they enable analogical reasoning.

Participants in this study are patients undergoing invasive monitoring for suspected focal epilepsy with depth electrodes. Subjects will conduct a variety of cognitive tests on a computer placed in front of them during their hospital stay. Participating hospitals in this study are Cedars-Sinai, UC Davis, and Barrow Neurological Institute.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Intractable epilepsy, undergoing invasive monitoring
  • Age ≥18
  • Full Scale Intelligence Quotient > 70
  • Ability to comprehend and perform simple behavioral tasks by pressing buttons on laptop computer in response to questions.

Exclusion criteria

  • Determination by clinicians and investigators that a patient is unable to complete the behavioral tasks required for the protocol due to either cognitive limits, psychological limits, or pain.

Treatment and study plan

Cedrus RB-844 response pad; Adtech Behnke-Fried micro-electrodes; Neurolynx electrophysiology system; Blackrock Cerestim stimulator

Behavioral

Devices listed are components of a single intervention that includes: Record patient responses (Cedrus RB-844), record neuronal activity (Neurolynx) from electrodes (Adtech Behnke-Fried), apply intermittent electrical stimulation (Blackrock Cerestim)

Primary outcomes

  1. Neuronal population activity

    Time frame: 3 years

    Proportion of experiment sessions in which abstract representation emerged following successful learning of the task by the subject.

  2. Facilitation of generalization

    Time frame: 3 years

    Strength of correlation between the presence of abstract representations at the neuronal level and the subjects ability to perform generalization.

  3. Effect of electrical stimulation

    Time frame: 3 years

    Proportion of experiment sessions in which electrical stimulation to the hippocampus disrupted abstract representations.

Sponsors and collaborators

Lead sponsor

Cedars-Sinai Medical Center

Other

Collaborators

  • Barrow Neurological Institute
  • Columbia University
  • National Institute on Deafness and Other Communication Disorders (NIDCD)
  • University of California, Davis
  • University of California, Los Angeles

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Mar 6, 2026
Registry last updated
Jun 3, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.